Cargando…

Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours

In recent years, much research has been focused on the field of adoptive cell therapies (ACT) that use native or genetically modified T cells as therapeutic tools. Immunotherapy with T cells expressing chimeric antigen receptors (CARs) demonstrated great success in the treatment of haematologic mali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chruściel, Elżbieta, Urban-Wójciuk, Zuzanna, Arcimowicz, Łukasz, Kurkowiak, Małgorzata, Kowalski, Jacek, Gliwiński, Mateusz, Marjański, Tomasz, Rzyman, Witold, Biernat, Wojciech, Dziadziuszko, Rafał, Montesano, Carla, Bernardini, Roberta, Marek-Trzonkowska, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140076/ https://www.ncbi.nlm.nih.gov/pubmed/32183246 http://dx.doi.org/10.3390/cancers12030683

Ejemplares similares

What Inhibits Natural Killers’ Performance in Tumour
por: Papak, Ines, et al.
Publicado: (2022)

The effects of RNA editing in cancer tissue at different stages in carcinogenesis
por: Kurkowiak, Małgorzata, et al.
Publicado: (2021)

Trimodality Treatment of Superior Sulcus Non-Small Cell Lung Cancer: An Institutional Series of 47 Consecutive Patients
por: Rzyman, Witold, et al.
Publicado: (2023)

Antigenic Challenge Influences Epigenetic Changes in Antigen-Specific T Regulatory Cells
por: Iwaszkiewicz-Grzes, Dorota, et al.
Publicado: (2021)

Therapy with CD4(+)CD25(+) T regulatory cells – should we be afraid of cancer?
por: Gliwiński, Mateusz, et al.
Publicado: (2019)

Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity
por: Piekarska, Karolina, et al.
Publicado: (2022)

A narrative review of invasive diagnostics and treatment of early lung cancer
por: Dziedzic, Robert, et al.
Publicado: (2021)

Early results of a trimodality treatment for superior sulcus tumors
por: Łapiński, Mariusz, et al.
Publicado: (2014)

Safety of Surgery after Neoadjuvant Targeted Therapies in Non-Small Cell Lung Cancer: A Narrative Review
por: Marjanski, Tomasz, et al.
Publicado: (2021)

Catamenial pneumothorax – a review of the literature
por: Marjański, Tomasz, et al.
Publicado: (2016)

Folate/homocysteine metabolism and lung cancer risk among smokers
por: Stanisławska-Sachadyn, Anna, et al.
Publicado: (2019)

Younger patients operated for lung cancer have a better prognosis
por: Marjanski, Tomasz, et al.
Publicado: (2020)

500 Meters Is a Result of 6-Minute Walk Test Which Differentiates Patients with High and Low Risk of Postoperative Complications after Lobectomy—A Validation Study
por: Marjanski, Tomasz, et al.
Publicado: (2021)

Physiological Biomarkers Assessed by Low-Tech Exercise Tests Predict Complications and Overall Survival in Patients Undergoing Pneumonectomy Due to Lung Cancer
por: Marjanski, Tomasz, et al.
Publicado: (2021)

Successful Treatment of Persistent SARS-CoV-2 Infection in a B-Cell Depleted Patient with Activated Cytotoxic T and NK Cells: A Case Report
por: Jassem, Jacek, et al.
Publicado: (2021)

Autoimmunity and Cancer—Two Sides of the Same Coin
por: Sakowska, Justyna, et al.
Publicado: (2022)

The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
por: Urban-Wojciuk, Zuzanna, et al.
Publicado: (2019)

Performance of various risk prediction models in a large lung cancer screening cohort in Gdańsk, Poland—a comparative study
por: Ostrowski, Marcin, et al.
Publicado: (2021)

Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy
por: Gliwiński, Mateusz, et al.
Publicado: (2020)

Complex EGFR mutations in non-small cell lung cancer: a distinct entity?
por: Bieńkowski, Michał, et al.
Publicado: (2022)

Cell-Based Therapies with T Regulatory Cells
por: Gliwiński, Mateusz, et al.
Publicado: (2017)

Radiotherapy in thoracic malignancies: the preface
por: Jassem, Jacek, et al.
Publicado: (2021)

Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents
por: Wrona, Anna, et al.
Publicado: (2021)

High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia
por: Stefańska, Katarzyna, et al.
Publicado: (2023)

Editorial on implementation of CT-based screening of lung cancer
por: Rzyman, Witold
Publicado: (2021)

Real-world clinical outcomes of first-generation and second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large cohort of European non-small-cell lung cancer patients
por: Pluzanski, Adam, et al.
Publicado: (2020)

Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer
por: Petrie, Kevin, et al.
Publicado: (2020)

Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)
por: Łazar-Poniatowska, Małgorzata, et al.
Publicado: (2021)

Regulatory T Cells-Related Genes Are under DNA Methylation Influence
por: Piotrowska, Magdalena, et al.
Publicado: (2021)

Incidentally diagnosed pulmonary nodule: a diagnostic algorithm
por: Dziedzic, Robert, et al.
Publicado: (2014)

Differential RNA editing landscapes in host cell versus the SARS-CoV-2 genome
por: Kurkowiak, Małgorzata, et al.
Publicado: (2023)

Harnessing the Effect of Adoptively Transferred Tumor-Reactive T Cells on Endogenous (Host-Derived) Antitumor Immunity
por: Nesbeth, Yolanda, et al.
Publicado: (2010)

Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review
por: Tomasik, Bartłomiej, et al.
Publicado: (2023)

Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer
por: Fereydouni, Mohammad, et al.
Publicado: (2022)

Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer
por: Neo, Shi Yong, et al.
Publicado: (2023)

Lung exposure during simultaneous myocardial revascularization and lung surgery through median sternotomy
por: Jagielak, Dariusz, et al.
Publicado: (2016)

Pulsed-dose-rate peri-operative brachytherapy as an interstitial boost in organ-sparing treatment of breast cancer
por: Serkies, Krystyna, et al.
Publicado: (2016)

Contralateral esophageal sparing technique in definitive radiotherapy for non-small cell lung cancer: dosimetric parameters and normal tissue complication probability modeling
por: Łazar-Poniatowska, Małgorzata, et al.
Publicado: (2022)

The Influence of Radiotherapy on the Function of the Left and Right Ventricles in Relation to the Radiation Dose Administered to the Left Anterior Descending Coronary Artery—From a Cardiologist’s Point of View
por: Nabialek-Trojanowska, Izabela, et al.
Publicado: (2022)

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number
por: Szutowicz-Zielinska, Ewa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nvgu1cakf08lat2auh7no2pjht